Literature DB >> 17151104

Fitness landscape of human immunodeficiency virus type 1 protease quasispecies.

Guerau Fernàndez1, Bonaventura Clotet, Miguel Angel Martínez.   

Abstract

Here we show, at a high resolution (1%), the human immunodeficiency virus type 1 (HIV-1) protease gene quasispecies landscape from three infected naïve individuals. A huge range of genetic configurations was found (67%, 71%, and 80% of the nucleotide clones from the three individuals, respectively, were different), and these configurations created a dense net that linked different parts of the viral population. Similarly, a vast diversity of different protease activities was also found. Importantly, 65% of the analyzed enzymes had detectable protease activity, and 11% of the minority individual variants showed similar or better fitness than the master (most abundant) enzyme, suggesting that the viral complexity in this genomic region does not exclusively depend on the enzyme's catalytic efficiency. Several high-fitness minority variants had only one substitution compared to the master sequence, supporting the possibility that the rugged HIV-1 protease quasispecies fitness landscape may be formed by a continuous network that can be traversed by single mutational steps without passing through defective or less-adapted proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17151104      PMCID: PMC1865935          DOI: 10.1128/JVI.01594-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Contribution of Taq polymerase-induced errors to the estimation of RNA virus diversity.

Authors:  M A Bracho; A Moya; E Barrio
Journal:  J Gen Virol       Date:  1998-12       Impact factor: 3.891

2.  A genetic screen for the isolation and characterization of site-specific proteases.

Authors:  H J Sices; T M Kristie
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

3.  TreeView: an application to display phylogenetic trees on personal computers.

Authors:  R D Page
Journal:  Comput Appl Biosci       Date:  1996-08

4.  Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population.

Authors:  A J Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

5.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.

Authors:  T W Chun; L Carruth; D Finzi; X Shen; J A DiGiuseppe; H Taylor; M Hermankova; K Chadwick; J Margolick; T C Quinn; Y H Kuo; R Brookmeyer; M A Zeiger; P Barditch-Crovo; R F Siliciano
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

6.  PAML: a program package for phylogenetic analysis by maximum likelihood.

Authors:  Z Yang
Journal:  Comput Appl Biosci       Date:  1997-10

7.  Rapid, transient changes at the env locus of plasma human immunodeficiency virus type 1 populations during the emergence of protease inhibitor resistance.

Authors:  E L Delwart; H Pan; A Neumann; M Markowitz
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

8.  Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy.

Authors:  M Nijhuis; C A Boucher; P Schipper; T Leitner; R Schuurman; J Albert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

9.  Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection.

Authors:  S M Wolinsky; B T Korber; A U Neumann; M Daniels; K J Kunstman; A J Whetsell; M R Furtado; Y Cao; D D Ho; J T Safrit
Journal:  Science       Date:  1996-04-26       Impact factor: 47.728

10.  Memory in retroviral quasispecies: experimental evidence and theoretical model for human immunodeficiency virus.

Authors:  Carlos Briones; Esteban Domingo; Carmen Molina-París
Journal:  J Mol Biol       Date:  2003-08-01       Impact factor: 5.469

View more
  21 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Rapid construction of empirical RNA fitness landscapes.

Authors:  Jason N Pitt; Adrian R Ferré-D'Amaré
Journal:  Science       Date:  2010-10-15       Impact factor: 47.728

3.  Quantitative modeling of virus evolutionary dynamics and adaptation in serial passages using empirically inferred fitness landscapes.

Authors:  Hyung Jun Woo; Jaques Reifman
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

4.  Similarities between Human Immunodeficiency Virus Type 1 and Hepatitis C Virus Genetic and Phenotypic Protease Quasispecies Diversity.

Authors:  Miguel Angel Martinez; Maria Nevot; Ana Jordan-Paiz; Sandra Franco
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

5.  Multiple scales of selection influence the evolutionary emergence of novel pathogens.

Authors:  Miran Park; Claude Loverdo; Sebastian J Schreiber; James O Lloyd-Smith
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-04       Impact factor: 6.237

6.  A quantitative quasispecies theory-based model of virus escape mutation under immune selection.

Authors:  Hyung-June Woo; Jaques Reifman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

Review 7.  Viral quasispecies.

Authors:  Raul Andino; Esteban Domingo
Journal:  Virology       Date:  2015-03-29       Impact factor: 3.616

Review 8.  Quasispecies and virus.

Authors:  Esteban Domingo; Celia Perales
Journal:  Eur Biophys J       Date:  2018-02-03       Impact factor: 1.733

9.  Co-lethality studied as an asset against viral drug escape: the HIV protease case.

Authors:  Sophie Brouillet; Thomas Valere; Emmanuelle Ollivier; Laurent Marsan; Anne Vanet
Journal:  Biol Direct       Date:  2010-06-17       Impact factor: 4.540

10.  Quasispecies-like behavior observed in catalytic RNA populations evolving in a test tube.

Authors:  Carolina Díaz Arenas; Niles Lehman
Journal:  BMC Evol Biol       Date:  2010-03-23       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.